New cell implant aims to free type 1 diabetes patients from severe hypoglycemia
Disease control
Not yet recruiting
This early-stage study tests a new treatment called SR-02 for adults with type 1 diabetes who experience dangerously low blood sugar. The treatment involves implanting insulin-producing cells into the belly lining. Nine participants will receive the implant and must take lifelong…
Phase: PHASE1, PHASE2 • Sponsor: Seraxis • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC